ZEB1 and non-small cell lung carcinoma: Likewise, studies have shown that lncRNA ZEB1-AS1 contributes to a higher risk of bone metastases in non-small-cell lung cancer (NSCLC) by facilitating the epithelial-to-mesenchymal transition (EMT), which enables cancer spread.